During the recent BIO-Europe partnering conference, Mike Ward, global director of content for Informa Pharma Insights, chats to Ruediger Jankowsky, managing director of Cinfa Biotech, about the company's pipeline of biosimilar products for oncology and inflammatory diseases.
Cinfa Biotech has one product under regulatory review in Europe, a biosimilar version of Amgen Inc.’s Neulasta (pegfilgrastim), which...







